The U.S. Food and Drug Administration (FDA) approved an algorithm used in hospitals to predict the sudden death of patients.
How does it work?
It is a product of ExcelMedical and has a system - called The Wave Clinical Platform - that monitors the patient's vital signs: it sends alerts when it believes there is a potential risk of a heart attack or respiratory failure. It does about six hours before the patient perceives the symptoms. This is the first algorithm of its kind, approved by the FDA.
The creators hope that in this way the death of many patients can be prevented, especially in hospitals where doctors and nurses are not enough. Wave Clinical Platform constantly monitors the physiological changes of the patient. In addition to alerting doctors, it gives them a medical history with information they can check from their cell phones, even when they are not in the hospital.
What makes it different?
The innovative thing about Wave is that it not only retrieves information from the patient, but also takes the changes in the body and analyzes them together.
Regular monitors detect symptoms in isolation, but this algorithm relates them and emits a percentage of risk for various conditions.
